![Foto3](http://old.institutmacula.com/wp-content/uploads/Foto3-300x110.jpg)
· 19/03/2014
TREND: Estudio fase IIIb multicentrico, randomizado, de 12 meses de seguimiento con evaluador de la agudeza visual enmascarado, para evaluar la eficacia y la seguridad de ranibizumab 0,5mg en un régimen de tratar e extender comparado con un régimen mensual, en pacientes con degeneración macular neovascular asociada a la edad
![Foto1_def2](http://old.institutmacula.com/wp-content/uploads/Foto1_def2-300x110.jpg)
· 19/03/2014
MACBETH. Assaig clínic en fase IV per a avaluar l’eficàcia d’aflibercept a pacients amb degeneració macular associada a l’edat (DMAE) neovascular, sense resposta optima a repetides injeccions mensuals intravitrees d’anti VEGF-A
![DMAE EX](http://old.institutmacula.com/wp-content/uploads/DMAE-EX-300x110.jpg)
· 23/01/2014
Advocating for Improved treatment and Outcomes for Wet Age-related Macular Degeneration. A report based on an International Expert Summit.
![DMAE exudativa activa](http://old.institutmacula.com/wp-content/uploads/DMAE-exudativa-activa-300x110.png)
· 30/01/2014
Expert Clinical Guide to the Management of Exudative Age-Related Macular Degeneration
![5074_AVI](http://old.institutmacula.com/wp-content/uploads/5074_AVI2-300x110.jpg)
· 30/09/2013
Bimonthly half-dose ranibizumab in large pigment epithelial detachment and retinal angiomatous proliferation with high risk of retinal pigment epithelium tear: a case report. 2013.
![_MG_8226](http://old.institutmacula.com/wp-content/uploads/MG_8226-300x110.jpg)
· 31/08/2013
Intravitreal Injections: A Healthcare Failure Modes and Effects Analysis. 2013, Aug.
![gradiente](http://old.institutmacula.com/wp-content/uploads/gradiente-300x110.jpg)
· 01/04/2012
Intra and interobserver agreement in the classification of fundus autofluorescence patterns in geographic atrophy secondary to age-related macular degeneration.
![FAF-Hiporeflective](http://old.institutmacula.com/wp-content/uploads/FAF-Hiporeflective-300x110.jpg)
· 01/07/2012
Hyporeflective wedge-shaped band in geographic atrophy secondary to age-related macular degeneration: a little-understood spectral domain optical coherence tomography finding.
![hemorragia subretinal](http://old.institutmacula.com/wp-content/uploads/NVC-ebeling-2-300x110.jpg)
· 01/12/2012
FUSION regimen: ranibizumab in treatment-naïve patients with exudative age-related macular degeneration and high visual acuity.
![multifocal ERG](http://old.institutmacula.com/wp-content/uploads/multifocal-ERG-e1365506866596-300x110.png)
· 01/07/2011
Update on Geographic Atrophy in Age-Related Macular Degeneration.
![Foto51_3](http://old.institutmacula.com/wp-content/uploads/Foto51_3-300x110.png)
· 01/04/2010
Ranibizumab in the treatment of choroidal neovascularization on the border of an inferior staphyloma associated with tilted disc syndrome.
![40MPU-CR-GLY-SYN_Snapshot_01 para RESULTADOS ALFA-SYN 1](http://old.institutmacula.com/wp-content/uploads/40MPU-CR-GLY-SYN_Snapshot_01-para-RESULTADOS-ALFA-SYN-1-300x110.jpg)
· 01/05/2011
Management of Retinal Vein Occlusion – Consensus Document.
![color atrofia](http://old.institutmacula.com/wp-content/uploads/color-atrofia-300x110.jpg)
· 01/02/2010
Transconjunctival sutureless vitrectomy with tissue plasminogen activator, gas and intravitreal bevacizumab in the management of predominantly hemorrhagic age-related macular degeneration.
![_MG_7582](http://old.institutmacula.com/wp-content/uploads/MG_7582-300x110.jpg)
· 24/04/2010
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
![AF EMQ](http://old.institutmacula.com/wp-content/uploads/AF-EMQ-300x110.jpg)
· 01/12/2011
Postsurgical cystoid macular edema